Clinical trial

Open Label High Dose Ropinirole (Requip) Study for Patients With Parkinson's Disease

NCT00260793

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2005-11-01

PhasePHASE3

Study timeline

Study start (unknown)2005-11-01Date precision: month

Registry last updated2006-02-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson's Diseaseunresolved

Interventions

Ropinirole HydrochlorideDRUG · verified · RxNorm: ropinirole hydrochloride

Sponsors & collaborators

Agarwal, Pinky, M.D.lead sponsor

Colorado Neurologycollaborator

GlaxoSmithKlinecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00260793 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.